Celebrating Scientific Advancement Amarin applauds the groundbreaking work addressing sHTG and rare genetic disorders such as familial chylomicronemia syndrome (FCS). These advances help drive patient ...
VASCEPA was associated with an increased risk (12% vs 10%) of bleeding in a double-blind, placebo-controlled trial. The incidence of bleeding was greater in patients receiving concomitant ...
Amarin Corporation plc (NASDAQ:AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced select preliminary unaudited 2025 financial ...
Oman’s shoreline has always been central to the country’s survival, economy and cultural identity. In Sur, a city in the ...
Across the world, healthcare systems are shifting toward value - based models - ones that prioritise experience, outcomes, ...
Excellence in business comes in many forms. For some companies, it’s a creative use of artificial intelligence to drive growth. For others, it’s a viral marketing campaign or a game-changing invention ...
January walks and runs along the Fox River in Illinois brought back treasured outdoor memories of North Dakota trails along ...